Afrezza is a new super-rapid inhalable meal-time insulin that has been available since early 2015. So far, the’ experiences of Afrezza users (Type 1 and Type 2 diabetics) have confirmed that Afrezza has many advantages (over rapid-acting analog insulin (RAAs)).  Here are some of these advantages (for discussion of the side effects of Afrezza, please refer to this article: Afrezza: Side Effect):

• Better A1Cs
• More time-in-zone
• Peak action in 15 minutes (fast acting in correcting BG highs)
• Action finished in 90 minutes (no worry about IOB or insulin stacking)
• Less hypos
• Precise dosing not required (and no complex carb counting needed)
• Spontaneousness (meaning one can enjoy more varieties of food (and in general, life))
• Reduce risks for complications
• Improve quality of life
• Reduce burden of family members
• Device the size of a whistle – discreet and easy to carry around
• No needles - inhaled
• Help lose weight
• Pump-free freedom
• Reduce insulin resistance
• Flexibility (in change routine with no impact on blood sugar)
• Other advantages (no smell, no taste; real human insulin - not an modified analogue; better compliance)

Continue reading Afrezza Review: Diabetics Confirm its Advantages →